Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Fine-tuning of chemical structure of mRNA carriers

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
Posted On: 06/25/2015 12:15:10 AM
Avatar
Posted By: News Desk 2018
Fine-tuning of chemical structure of mRNA carriers for clinical applications

KAWASAKI CITY, Japan, June 25, 2015 (GLOBE NEWSWIRE) -- With a view to improving gene therapy, Kazunori Kataoka at the University of Tokyo and collaborators, including researchers affliated with the Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT), have completed a study to determine the best design of polycation structure for delivering mRNA. The researchers concluded that the sophisticated molecular design of carriers is important for realizing clinical application using nucleic acids drugs.

The findings are published in The Journal of the American Chemical Society 136 (2014)

This research is being conducted in collaboration with the Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT), the flagship science and technology innovation hub of Kawasaki City located in the Tonomachi area of the Keihin Industrial Region that spans Tokyo and Kanagawa Prefecture and Tokyo International Airport. KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

More information about Kawasaki INnovation Gateway at SKYFRONT: http://inewsletter-king-skyfront.jp/en/about

There is much interest in messenger RNA (mRNA) as a potential candidate for nucleic acids drug. However, the very labile nature of mRNA has hindered its clinical applications. Polyion complex formed from mRNA and polycations, which is termed 'Polyplex', can protect mRNA from enzymatic degradation and enhance its cellular uptake. Fine-tuning of the chemical structure of polycations dramatically improve the ability of polyplex to deliver mRNA.

Prof. Kazunori Kataoka and co-workers at the University of Tokyo synthesized the polyaspartamides possessing the different number of aminoethylene repeats in their side chain. By applying the polyaspartamides for mRNA carriers, they found that the polyaspartamides possessing odd number of aminoethylene repeats (PA-Os) provided more persistent protein expression compared with those possessing even number repeats (PA-Es).

Prof. Kataoka and his team also revealed that, despite lower capacity of endosomal escape than PA-Es, the carriers composed of PA-Os had high stability in the cytoplasm allowing retention of mRNA stably inside the carriers. Eventually, PA-Os can provide protein expression in a long and sustained manner. These feature are in sharp contrast to the case of DNA delivery, where PA-Es exhibited high capacity due to the facilitated endosomal escape.

The researchers concluded that the sophisticated molecular design of carriers is important for realizing clinical application using nucleic acids drugs.

Reference and affiliations 1. Hirokuni Uchida,† Keiji Itaka,† Takahiro Nomoto,‡ Takehiko Ishii,‡ Tomoya Suma,∥ Masaru Ikegami,† Kanjiro Miyata,† Makoto Oba,⊥ Nobuhiro Nishiyama,# and Kazunori Kataoka*,†,‡,§. Modulated protonation of side chain aminoethylene repeats in N substituted polyaspartamides promotes mRNA transfection. The American Chemical Society 136 (35), pp 12396–12405 (2014).

†Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, ‡Department of Bioengineering, Graduate School of Engineering, and §Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8656, Japan

∥Department of Chemical and Biomolecular Engineering, The University of Melbourne, Victoria 3010, Australia

⊥Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan

#Polymer Chemistry Division, Chemical Resources Laboratory, Tokyo Institute of Technology, R1-11, 4529 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan *corresponding author email address: kataoka(at)bmw.t.u-tokyo.ac.jp

About KING SKYFRONT

KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

KING SKYFRONT is located on the opposite side of the Tama River that separates Tokyo International Airport (also known as Haneda Airport) and the Tonomachi district of Kawasaki. The Airport plays an important role in the globalization of the innovative activities of scholars, industrialists and City administrators based at KING SKYFRONT.

Website

http://www.city.kawasaki.jp/en/category/132-5...0-0-0.html

KING SKYFRONT Concept Video

https://www.youtube.com/watch?v=GKh1FCPYWmI&i...bRZbeNjqwt

Further information

Kawasaki City, Japan, Coastal Area International Strategy Office General Planning Bureau, City of Kawasaki,

1 Miyamoto-cho, Kawasaki-ku, Kawasaki-city, Kanagawa 210-8577, Japan EMAIL: 20rinkai(at)city.kawasaki.jp

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://uk.prweb.com/releases/2015/06/prweb12770181.htm

Kawasaki City, Japan, Coastal Area International Strategy Office Naoko Sato +81 442003634



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us